Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "drugs"
Home
Subcutaneous Revolution: Alteogen and BD Showcase Large-Volume Biologic Delivery Solution
As the development of high-dose biologic therapies accelerates across the biopharmaceutical industry, innovative drug-delivery systems designed to...
05/27/2026, 22:28 ET
The Ozempic Multiplier: Why Lifestyle Habits Still Dictate Heart Health in the GLP-1 Era
It has been three months since I started my once-weekly Ozempic injection. My blood sugar is clearly under control, and I’ve lost a little weight.
05/27/2026, 22:28 ET
From Relief to Toxicity: The Hidden Danger of Mixing Common Cold Medications
Many households keep a stock of leftover cold medicines, often accumulating various brands over time.
05/15/2026, 04:43 ET
When Healthy Foods Turn ‘Toxic’: 7 Fruits and Vegetables to Eat in Moderation
As people age, many begin incorporating health-focused foods into their diets with the belief that more is always...
05/08/2026, 06:56 ET
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
04/24/2026, 05:13 ET
Supplementing for Success: How to Match Your Nutrient Intake to Your Age
It is a common refrain: “I received these supplements as a gift, but I’m not sure if they’re actually right for me.
04/22/2026, 22:34 ET
The Silent Epidemic: How Housing Conditions Drive Heart-Damaging Chagas Disease
Even when infected, the body often provides no clear warning signs. Yet, decades later, the heart can deteriorate...
04/17/2026, 05:23 ET
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
04/09/2026, 01:13 ET
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?
A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
04/04/2026, 08:51 ET
Why Does the Same Chemotherapy Work Differently for Everyone? Cause of Treatment Failure Identified
Why is it that when given the same chemotherapy drug, some patients see remarkable recovery while others show no...
04/04/2026, 08:49 ET
Previous
7
8
9
10
11
Next